Global Wealth Management Investment Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Global Wealth Management Investment Advisory's PFE Position: Q1 2024 in Review
Global Wealth Management Investment Advisory sold out of Pfizer (PFE) in Q1 2024, closing a stake of 633 shares — an estimated $18.2K sold.
Global Wealth Management Investment Advisory first reported a position in PFE in Q4 2018 and held it in 21 quarters. The position peaked at $3.36M in Q4 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Global Wealth Management Investment Advisory reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Global Wealth Management Investment Advisory sold 633 Pfizer shares in Q1 2024, an estimated $18.2K.
- Global Wealth Management Investment Advisory first reported a position in Pfizer in Q4 2018 and held it in 21 quarters.
- Global Wealth Management Investment Advisory's Pfizer position peaked at $3.36M in Q4 2022.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Global Wealth Management Investment Advisory's 13F filing for Q1 2024, filed 10 May 2024.